MISTY R CHAMBERS
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical LAWRENCE, KS NPI 1629390331
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical KS ABBVIE INC. All categories
General Payments — all program years on this page
$4,156.36
- Category: General Payments
- Program years: PY2021–2024
- Record count: 269
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,432.40 across 91 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,347.41 | 90 |
| Education | $84.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $339.50 | 28 |
| Lilly USA, LLC | $160.01 | 14 |
| Astellas Pharma US Inc | $117.34 | 3 |
| Acerta Pharma LLC | $96.09 | 5 |
| Otsuka America Pharmaceutical, Inc. | $69.07 | 3 |
| ITI, Inc. | $66.21 | 4 |
| Abbott Laboratories | $51.85 | 3 |
| Novo Nordisk AS | $49.58 | 3 |
| Merck Sharp & Dohme Corporation | $44.34 | 2 |
| Amgen Inc. | $43.94 | 3 |
| Lundbeck LLC | $41.68 | 2 |
| Corium, Inc. | $35.57 | 3 |
| Ardelyx, Inc. | $34.24 | 2 |
| PFIZER INC. | $30.23 | 2 |
| GlaxoSmithKline, LLC. | $29.23 | 2 |
| OptiNose US, Inc. | $25.69 | 1 |
| Phadia US Inc. | $25.54 | 1 |
| Vanda Pharmaceuticals Inc. | $24.70 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.49 | 1 |
| Regeneron Healthcare Solutions, Inc. | $19.39 | 1 |
| Neos Therapeutics, LP | $16.81 | 1 |
| Supernus Pharmaceuticals, Inc. | $16.21 | 1 |
| Currax Pharmaceuticals LLC | $15.50 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.85 | 1 |
| Axsome Therapeutics, Inc. | $14.50 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.48 | 1 |
| Tris Pharma Inc | $13.36 | 1 |
By program year
Records — PY2024 (91)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.